Literature DB >> 16860159

Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.

Namasivayam Ambalavanan1, Waldemar A Carlo.   

Abstract

Bronchopulmonary dysplasia (BPD) leads to considerable mortality and morbidity in premature infants. Although mechanical ventilation is lifesaving in infants with respiratory distress syndrome (RDS), it may contribute to lung injury and subsequently to BPD. Appropriate ventilatory strategies for reducing BPD include redefining the goals for "adequate gas exchange," using less mechanical ventilation support, refining the methods of mechanical ventilation, and using alternative techniques. Permissive hypercapnia, permissive hypoxemia, minimal peak pressures, rapid rates, early therapeutic continuous positive airway pressure (CPAP), and rapid extubation may help reduce mechanical ventilation-induced lung injury and possibly reduce BPD. Newer techniques of ventilation such as volume-targeted ventilation are also promising. High frequency ventilation has not been proven to reduce BPD. There is a lack of evidence-based guidelines on management of infants with established BPD. Optimization of clinical care practices and ancillary therapies need to be combined with ventilatory strategies to prevent and manage BPD.

Entities:  

Mesh:

Year:  2006        PMID: 16860159     DOI: 10.1053/j.semperi.2006.05.006

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  9 in total

Review 1.  Chronic lung disease in newborns.

Authors:  M Jeeva Sankar; Ramesh Agarwal; Ashok K Deorari; Vinod K Paul
Journal:  Indian J Pediatr       Date:  2008-05-18       Impact factor: 1.967

2.  Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.

Authors:  Kosmas Sarafidis; Theodora Stathopoulou; Elisavet Diamanti; Vasiliki Soubasi; Charalambos Agakidis; Aikaterini Balaska; Vasiliki Drossou
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

Review 3.  Hypercapnia and hypocapnia in neonates.

Authors:  Wei Zhou; Wen Liu
Journal:  World J Pediatr       Date:  2008-08       Impact factor: 2.764

4.  Permissive hypercapnia in the management of congenital diaphragmatic hernia: our institutional experience.

Authors:  Christopher A Guidry; Tjasa Hranjec; Bradley M Rodgers; Bartholomew Kane; Eugene D McGahren
Journal:  J Am Coll Surg       Date:  2012-02-28       Impact factor: 6.113

Review 5.  Achieving and maintaining lung volume in the preterm infant: from the first breath to the NICU.

Authors:  Gianluca Lista; Andrés Maturana; Fernando R Moya
Journal:  Eur J Pediatr       Date:  2017-08-10       Impact factor: 3.183

6.  A new method for continuous monitoring of chest wall movement to characterize hypoxemic episodes during HFOV.

Authors:  Dan Waisman; Carmit Levy; Anna Faingersh; Fatmi Ifat Colman Klotzman; Eugene Konyukhov; Irena Kessel; Avi Rotschild; Amir Landesberg
Journal:  Intensive Care Med       Date:  2011-04-29       Impact factor: 17.440

7.  Intramuscular Followed by Oral Vitamin A Supplementation in Neonates with Birth Weight from 750 to 1250 g: A Randomized Controlled Trial.

Authors:  S Giridhar; Jogender Kumar; Savita Verma Attri; Sourabh Dutta; Praveen Kumar
Journal:  Indian J Clin Biochem       Date:  2019-01-03

8.  Early extubation is not associated with severe intraventricular hemorrhage in preterm infants born before 29 weeks of gestation. Results of an EPIPAGE-2 cohort study.

Authors:  Marie Chevallier; Pierre-Yves Ancel; Héloïse Torchin; Laetitia Marchand-Martin; Elsa Lorthe; Patrick Truffert; Pierre Henri Jarreau; Jean Christophe Roze; Véronique Pierrat; Stéphane Marret; Olivier Baud; Valérie Benhammou; Anne Ego; Thierry Debillon
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

9.  A comparison of KL-6 and Clara cell protein as markers for predicting bronchopulmonary dysplasia in preterm infants.

Authors:  Keyi Wang; Xianmei Huang; Hui Lu; Zhiqun Zhang
Journal:  Dis Markers       Date:  2014-08-27       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.